Compare Ecolab Inc. (ECL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs GeneDx Holdings Corp — how do they compare? Ecolab Inc. trades at $278.45 (market cap $79.79B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Ecolab Inc. is far larger — about 32.7× GeneDx Holdings Corp's market cap, and Ecolab Inc. pays a 1.03% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| ECL | WGS | |
|---|---|---|
Market Cap | $79.79B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $308.35 | $167.51 |
52-Week Low | $245.73 | $34.51 |
Enterprise Value | $88.57B | $2.48B |
Dividend Yield | 1.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecolab Inc. (ECL) trades at $278.02, down 2.24% on the day, with a bullish technical outlook supported by moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates with $2.09 versus $2.08 expected, driven by 5% organic sales growth. Recent acquisition of CoolIT for $4.75 billion strengthens its AI cooling portfolio. Valuation ratios are elevated, with a P/E of 38.21 and P/S of 4.8, reflecting premium pricing for its consistent profitability and market position.
The outlook remains positive with a consensus price target of $327.90, implying 18% upside, supported by 78% analyst buy ratings. Key risks include high valuation sensitivity to earnings misses, as seen in Q1 2026, and rising input costs pressuring margins. Long-term growth is underpinned by digital expansion and high-tech segment strength, but investors should monitor execution on guidance and macroeconomic pressures on industrial demand.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
